
Launch of Gnomica Biotherapy
We are proud to announce the launch of Gnomica Biotherapy, a new biotech company emerging from discoveries made in Ravid Straussman's lab at the Weizmann Institute of Science!
Gnomica is pioneering a novel approach to cancer treatment, developing small-molecule drug inhibitors targeting bacterial functions in the human body, a critical and often overlooked factor in treatment resistance.

Quantum Art to Advance Scalable Quantum Computing Through Logical Qubit Compiler and NVIDIA CUDA-Q Integration
Quantum Art to Advance Scalable Quantum Computing Through Logical Qubit Compiler and NVIDIA CUDA-Q Integration
The latest advancements in quantum computing, including a new logical qubit compiler and integration with NVIDIA CUDA-Q, are set to significantly boost the scalability of quantum systems.
This is a huge leap forward for the industry, paving the way for more powerful and accessible quantum solutions.

UltraSight™ Receives KFDA Regulatory Approval for AI Guidance System, Expanding Global Access to Cardiac Imaging
UltraSight™ Receives KFDA Regulatory Approval for AI Guidance System, Expanding Global Access to Cardiac Imaging

Top 60 - Non-profit research institutes and Government agencies granted US utility patents

Phytolon and Ginkgo Bioworks announce natural food colour production milestone
Biotech start-ups Phytolon and Ginkgo Bioworks have announced the successful completion of the second development milestone in their multi-product collaboration to produce natural food colours.

ProFuse Announces New Drug Development Platform for Muscle Loss Prevention Medication
Weight loss is a serious issue amongst Americans. While obesity is the main condition related to this issue, weight loss is also a major concern for many patients. It’s not uncommon for people to lose weight either directly from being sick or as a side effect of medication.

UltraSight to Expand Access to Echocardiographic Monitoring for Obstructive Hypertrophic Cardiomyopathy Patients
UltraSight, a spinoff company of Yeda, Expands Access to Echocardiographic Monitoring for Obstructive Hypertrophic Cardiomyopathy Patients
“By applying the power of machine learning to imaging, our aim is to streamline patient cardiac workflows for better, more efficient, and effective care” (Davidi Vortman, CEO)

80 Acres Farms Announces 2024 Capital Raises and Acquisitions
80 Acres Farms announced capital raises totaling $115 million and the acquisition of Plantae Biosciences, a spinoff company of YEDA.
The acquisition of Plantae Biosciences brings innovative plant breeding technology to 80 Acres Farms and its technology-focused subsidiary, Infinite Acres.
Since 2020, Plantae has collaborated with the Weizmann Institute of Science on projects in accelerated plant breeding via an exclusive license agreement with Yeda. The world-class researchers who built Plantae are now operating as Infinite Acres Israel.

Yeda's Newsletter 01/2025
This edition highlights the activities of the Weizmann Innovation Nest (WIN), a cornerstone in transitioning groundbreaking research from the lab to impactful real-world applications. Additionally, it showcases the latest technological advancements, laboratory innovations, and spinoff companies emerging from the Weizmann Institute of Science.

Packaged Feeds partners with FreezeM to advance zero-waste insect farming
Packaged Feeds has partnered with FreezeM, a spinoff company of YEDA, to incorporate its PauseM product - a solution containing suspended black soldier fly (BSF) neonates with a 14-day shelf life - into its insect farming process.
Pages
